Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Conditioning Regimens

Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment for the BM dysfunction seen in patients with Shwachman–Diamond syndrome (SDS). Historically, these patients have fared poorly with intensive conditioning regimens with increased regimen-related toxicity especially involving the heart and lungs. We report our institutional experience with a reduced-intensity-conditioning protocol in seven patients with SDS and BM aplasia or myelodysplastic syndrome/AML. The preparative regimen consisted of Campath-1H, fludarabine and melphalan. Four patients received matched related marrow and three received unrelated stem cells (two PBSCs and one marrow). All but one was 8 of 8 allele HLA matched. All patients established 100% donor-derived hematopoiesis. No patient in this cohort developed grades III–IV GVHD. One patient had grade II skin GVHD that responded to systemic corticosteroids and one had grade I skin GVHD, treated with topical corticosteroids. Two out of seven patients developed bacterial infections in the early post transplant period. Viral infections were seen in four out of seven patients and were successfully treated with appropriate antiviral therapy. All patients are currently alive. These data indicate that HSCT with reduced-intensity conditioning is feasible in patients with SDS and associated with excellent donor cell engraftment and modest morbidity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Shwachman H, Diamond L, Oski F, Khaw K . The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964; 65: 645–663.

    Article  CAS  PubMed  Google Scholar 

  2. Bodian M, Sheldon W, Lightwood R . Congenital hypoplasia of the exocrine pancreas. Acta Paediatr 1964; 53: 282–293.

    Article  CAS  PubMed  Google Scholar 

  3. Aggett PJ, Cavanagh NPC, Matthew DJ, Pincott JR, Sutcliffe J, Harries JT . Shwachman's syndrome: a review of 21 cases. Arch Dis Child 1980; 55: 331–347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ginzberg H, Shin J, Ellis L, Morrison J, Ip W, Dror Y et al. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 1999; 135: 81–88.

    Article  CAS  PubMed  Google Scholar 

  5. Berrocal T, Simón MJ, al-Assir I, Prieto C, Pastor I, de Pablo L et al. Shwachman–Diamond syndrome: clinical, radiological and sonographic aspects. Pediatr Radiol 1995; 25: 289–292.

    Article  CAS  PubMed  Google Scholar 

  6. Robberecht E, Nachtegaele P, Van Rattinghe R, Afschrift M, Kunnen M, Verhaaren R . Pancreatic lipomatosis in the Shwachman–Diamond syndrome. Identification by sonography and CT-scan. Pediatr Radiol 1985; 15: 348–349.

    Article  CAS  PubMed  Google Scholar 

  7. Mack DR, Forstner GG, Wilschanski M, Freedman MH, Durie PR . Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology 1996; 111: 1593–1602.

    Article  CAS  PubMed  Google Scholar 

  8. Dror Y, Ginzberg H, Dalal I, Cherepanov V, Downey G, Durie P et al. Immune function in patients with Shwachman–Diamond syndrome. Br J Haematol 2001; 114: 712–717.

    Article  CAS  PubMed  Google Scholar 

  9. Huijgens P, van der Veen E, Meijer S, Muntinghe O . Syndrome of Shwachman and leukemia. Scand J Haematol 1977; 18: 20–24.

    Article  CAS  PubMed  Google Scholar 

  10. Smith OP, Hann IM, Chessells JM, Reeves BR, Milla P . Haematological abnormalities in Shwachman–Diamond syndrome. Br J Haematol 1996; 94: 279–284.

    Article  CAS  PubMed  Google Scholar 

  11. Dokal I, Rule S, Chen F, Potter M, Goldman J . Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman–Diamond syndrome. Br J Haematol 1997; 99: 171–173.

    Article  CAS  PubMed  Google Scholar 

  12. Dror Y, Freedman MH . Malignant myeloid transformation with isochromosome 7q in Shwachman–Diamond syndrome. Leukemia 1998; 12: 1591–1595.

    Article  CAS  PubMed  Google Scholar 

  13. Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, et al., French Severe Chronic Neutropenia Study Group. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005; 90: 45–53.

    Google Scholar 

  14. Alter BP, Young NS . Shwachman Diamond syndrome. In: Nathan DG, Orkin SH (eds). Nathan and Oski's Hematology of Infancy and Childhood, 5th edn, vol 1 WB Saunders: Philadelphia, 1997, pp 276–278.

    Google Scholar 

  15. Tsai PH, Sahdev I, Herry A, Lipton JM . Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman–Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol 1990; 12: 472–476.

    Article  CAS  PubMed  Google Scholar 

  16. Okcu F, Roberts WM, Chan KW . Bone marrow transplantation in Shwachman–Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplant 1998; 21: 849–851.

    Article  CAS  PubMed  Google Scholar 

  17. Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C, et al., EBMT Severe Aplastic Anaemia and Paediatric Diseases Working Party. Haematopoietic stem cell transplantation for Shwachman–Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol 2005; 131: 231–236.

    Article  PubMed  Google Scholar 

  18. Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B et al. Hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant 2005; 36: 787–792.

    Article  CAS  PubMed  Google Scholar 

  19. Barrios N, Kirkpatrick D, Regueira O, Wuttke B, McNeil J, Humbert J . Bone marrow transplant in Shwachman Diamond syndrome. Br J Haematol 1991; 79: 337–338.

    Article  CAS  PubMed  Google Scholar 

  20. Smith OP, Chan MY, Evans J, Veys P . Shwachman–Diamond syndrome and matched unrelated donor BMT. Bone Marrow Transplant 1995; 16: 717–718.

    CAS  PubMed  Google Scholar 

  21. Arseniev L, Diedrich H, Link H . Allogeneic bone marrow transplantation in a patient with ShwachmanDiamond syndrome. Ann Hematol 1996; 72: 83–84.

    Article  CAS  PubMed  Google Scholar 

  22. Faber J, Lauener R, Wick F, Betts D, Filgueira L, Seger RA et al. Shwachman–Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis. Eur J Pediatr 1999; 158: 995–1000.

    Article  CAS  PubMed  Google Scholar 

  23. Fleitz J, Rumelhart S, Goldman F, Ambruso D, Sokol RJ, Pacini D et al. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman–Diamond syndrome. Bone Marrow Transplant 2002; 29: 75–79.

    Article  CAS  PubMed  Google Scholar 

  24. Cesaro S, Guariso G, Calore E, Gazzola MV, Destro R, Varotto S et al. Successful unrelated bone marrow transplantation for Shwachman–Diamond syndrome. Bone Marrow Transplant 2001; 27: 97–99.

    Article  CAS  PubMed  Google Scholar 

  25. Hsu JW, Vogelsang G, Jones RJ, Brodsky RA . Bone marrow transplantation in Shwachman–Diamond syndrome. Bone Marrow Transplant 2002; 30: 255–258.

    Article  CAS  PubMed  Google Scholar 

  26. Park SY, Chae MB, Kwack YG, Lee MH, Kim I, Kim YS et al. Allogeneic bone marrow transplantation in Shwachman–Diamond syndrome with malignant myeloid transformation. A case report. Korean J Intern Med 2002; 17: 204–206.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Cunningham J, Sales M, Pearce A, Howard J, Stallings R, Telford N et al. Does isochromosome 7q mandate bone marrow transplant in children with Shwachman–Diamond syndrome? Br J Haematol 2002; 119: 1062–1069.

    Article  PubMed  Google Scholar 

  28. Mitsui T, Kawakami T, Sendo D, Katsuura M, Shimizu Y, Hayasaka K . Successful unrelated donor bone marrow transplantation for Shwachman–Diamond syndrome with leukemia. Int J Hematol 2004; 79: 189–192.

    Article  PubMed  Google Scholar 

  29. Grewal SS, Barker JN, Davies SM, Wagner JE . Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101: 4233–4244. E-pub 9 January 2003.

    Article  CAS  Google Scholar 

  30. Vibhakar R, Radhi M, Rumelhart S, Tatman D, Goldman F . Successful unrelated umbilical cord blood transplantation in children with Shwachman–Diamond syndrome. Bone Marrow Transplant 2005; 36: 855–861.

    Article  CAS  PubMed  Google Scholar 

  31. Savilahti E, Rapola J . Frequent myocardial lesions in Shwachman syndrome. Eight fatal cases among 16 Finnish patients. Acta Paediatr Scand 1984; 73: 642–651.

    Article  CAS  PubMed  Google Scholar 

  32. Ferry C, Ouachée M, Leblanc T, Michel G, Notz-Carrére A, Tabrizi R et al. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant 2005; 35: 45–50.

    Article  CAS  PubMed  Google Scholar 

  33. Donadieu J, Stephan JL, Blanche S, Cavazzana-Calvo M, Baruchel A, Herbelin C et al. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 777–782.

    CAS  PubMed  Google Scholar 

  34. Dror Y, Freedman MH . Shwachman–Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood 2001; 97: 3011–3016.

    Article  CAS  PubMed  Google Scholar 

  35. Thornley I, Dror Y, Sung L, Wynn RF, Freedman MH . Abnormal telomere shortening in leucocytes of children with Shwachman–Diamond syndrome. Br J Haematol 2002; 117: 189–192.

    Article  PubMed  Google Scholar 

  36. Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K et al. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman–Diamond syndrome. Bone Marrow Transplant 2007; 39: 143–147.

    Article  CAS  PubMed  Google Scholar 

  37. Kuijpers TW, Alders M, Tool AT, Mellink C, Roos D, Hennekam RC . Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype–phenotype relationship. Blood 2005; 106: 356–361.

    Article  CAS  PubMed  Google Scholar 

  38. Mäkitie O, Ellis L, Durie PR, Morrison JA, Sochett EB, Rommens JM et al. Skeletal phenotype in patients with Shwachman–Diamond syndrome and mutations in SBDS. Clin Genet 2004; 65: 101–112.

    Article  PubMed  Google Scholar 

  39. Kawakami T, Mitsui T, Kanai M, Shirahata E, Sendo D, Kanno M et al. Genetic analysis of Shwachman–Diamond syndrome: phenotypic heterogeneity in patients carrying identical SBDS mutations. Tohoku J Exp Med 2005; 206: 253–259.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D Bhatla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhatla, D., Davies, S., Shenoy, S. et al. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome. Bone Marrow Transplant 42, 159–165 (2008). https://doi.org/10.1038/bmt.2008.151

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.151

Keywords

This article is cited by

Search

Quick links